Company intelligence / Profile preview
Throne Biotechnologies
Paramus, New Jersey, United Statesthronebio.com ↗
- Ownership
- Private
- Employees
- ~17
- Development stage
- Other
01
Overview
Over 10 years of clinical studies in Spain, China, and the United States have demonstrated clinical safety and efficacy in more than 200 patients aged 3-70 years. 70% of type 1 and type 2 diabetic patients demonstrated clinical efficacy with many patients reducing insulin and some becoming insulin independent[3][6].
- Therapeutic areas
- EndocrinologyImmunologyDermatologyInfectious Diseases
- Modalities
- Stem cell therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Fresenius Medical Care
Beyond the preview
Go deeper on Throne Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Throne Biotechnologies.